Original language | English |
---|---|
Pages (from-to) | 175-187 |
Number of pages | 13 |
Journal | JAMA-Journal of the American Medical Association |
Volume | 321 |
Issue number | 2 |
DOIs | |
Publication status | Published - 15 Jan 2019 |
Keywords
- INTERFERON-BETA
- GLATIRAMER ACETATE
- ALEMTUZUMAB
- NATALIZUMAB
- FINGOLIMOD
- DISABILITY
- MULTICENTER
- OUTCOMES
- TIME
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. / Brown, J. William L.; Coles, Alasdair; Horakova, Dana; Havrdova, Eva; Izquierdo, Guillermo; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Trojano, Maria; Lugaresi, Alessandra; Bergamaschi, Roberto; Grammond, Pierre; Alroughani, Raed; Hupperts, Raymond; McCombe, Pamela; Van Pesch, Vincent; Sola, Patrizia; Ferraro, Diana; Grand'Maison, Francois; Terzi, Murat; Lechner-Scott, Jeannette; Flechter, Schlomo; Slee, Mark; Shaygannejad, Vahid; Pucci, Eugenio; Granella, Franco; Jokubaitis, Vilija; Willis, Mark; Rice, Claire; Scolding, Neil; Wilkins, Alastair; Pearson, Owen R.; Ziemssen, Tjalf; Hutchinson, Michael; Harding, Katharine; Jones, Joanne; McGuigan, Christopher; Butzkueven, Helmut; Kalincik, Tomas; Robertson, Neil; Onofrj, Marco; De Luca, Giovanna; Di Tommaso, Valeria; Travaglini, Daniela; Pietrolongo, Erika; di Ioia, Maria; Farina, Deborah; Mancinelli, Luca; Hodgkinson, Suzanne; Oreja-Guevara, Celia; MSBase Study Grp.
In: JAMA-Journal of the American Medical Association, Vol. 321, No. 2, 15.01.2019, p. 175-187.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
AU - Brown, J. William L.
AU - Coles, Alasdair
AU - Horakova, Dana
AU - Havrdova, Eva
AU - Izquierdo, Guillermo
AU - Prat, Alexandre
AU - Girard, Marc
AU - Duquette, Pierre
AU - Trojano, Maria
AU - Lugaresi, Alessandra
AU - Bergamaschi, Roberto
AU - Grammond, Pierre
AU - Alroughani, Raed
AU - Hupperts, Raymond
AU - McCombe, Pamela
AU - Van Pesch, Vincent
AU - Sola, Patrizia
AU - Ferraro, Diana
AU - Grand'Maison, Francois
AU - Terzi, Murat
AU - Lechner-Scott, Jeannette
AU - Flechter, Schlomo
AU - Slee, Mark
AU - Shaygannejad, Vahid
AU - Pucci, Eugenio
AU - Granella, Franco
AU - Jokubaitis, Vilija
AU - Willis, Mark
AU - Rice, Claire
AU - Scolding, Neil
AU - Wilkins, Alastair
AU - Pearson, Owen R.
AU - Ziemssen, Tjalf
AU - Hutchinson, Michael
AU - Harding, Katharine
AU - Jones, Joanne
AU - McGuigan, Christopher
AU - Butzkueven, Helmut
AU - Kalincik, Tomas
AU - Robertson, Neil
AU - Onofrj, Marco
AU - De Luca, Giovanna
AU - Di Tommaso, Valeria
AU - Travaglini, Daniela
AU - Pietrolongo, Erika
AU - di Ioia, Maria
AU - Farina, Deborah
AU - Mancinelli, Luca
AU - Hodgkinson, Suzanne
AU - Oreja-Guevara, Celia
AU - MSBase Study Grp
PY - 2019/1/15
Y1 - 2019/1/15
KW - INTERFERON-BETA
KW - GLATIRAMER ACETATE
KW - ALEMTUZUMAB
KW - NATALIZUMAB
KW - FINGOLIMOD
KW - DISABILITY
KW - MULTICENTER
KW - OUTCOMES
KW - TIME
U2 - 10.1001/jama.2018.20588
DO - 10.1001/jama.2018.20588
M3 - Article
VL - 321
SP - 175
EP - 187
JO - JAMA-Journal of the American Medical Association
JF - JAMA-Journal of the American Medical Association
SN - 0098-7484
IS - 2
ER -